Library

feed icon rss

Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
Filter
  • Magnetic resonance imaging  (2)
  • Adverse events  (1)
Material
Years
Keywords
  • 1
    ISSN: 1432-1920
    Keywords: Children ; Chloral hydrate ; Magnetic resonance imaging ; Sedation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Orally administered chloral hydrate is the most widely used sedative in children undergoing MRI. We compared intermediate-and high-dose oral chloral hydrate in 97 consecutive children undergoing MRI in a prospective, controlled, double-blind, randomised clinical trial. There were 50 girls and 47 boys, mean weight (±SD) 14.7±6.4 kg, and mean age 38±31. The children were randomly allocated to receive chloral hydrate syrup either 70 mg/kg (group A,n=50) or 100 mg/kg (group B,n=47). These two groups were not significantly different in sex, weight, age, diagnosis or ambulatory medication. The mean initial dose (±SEM) was 64±2 mg/kg for group A and 93±2 mg/kg for group B. Because adequate sedation was not achieved, 14 patients in group A and 6 in group B required a second dose, giving a mean total dose of 70±2 mg/kg for group A and 96±2 mg/kg for group B. The percentage of successful examinations after the initial dose (A: 64%, B: 87%;p〈0.05) and the total dose (A: 92%, B: 100%;p=0.14) was higher in group B. Significant differences were found for the time of onset of sedation (A: 28±2 min, B: 21±1 min;p〈0.05), but not for the time to spontaneous awakening after the completion of the examination. The rate of adverse reactions was similar (A: 20%, B: 21%;p=1.00). We conclude that high-dose oral chloral hydrate improves the management of children undergoing MRI.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 2
    ISSN: 1432-1920
    Keywords: Key words Children ; Chloral hydrate ; Magnetic resonance imaging ; Sedation
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract Orally administered chloral hydrate is the most widely used sedative in children undergoing MRI. We compared intermediate- and high-dose oral chloral hydrate in 97 consecutive children undergoing MRI in a prospective, controlled, double-blind, randomised clinical trial. There were 50 girls and 47 boys, mean weight (± SD) 14.7 ± 6.4 kg, and mean age 38 ± 31. The children were randomly allocated to receive chloral hydrate syrup either 70 mg/kg (group A, n = 50) or 100 mg/kg (group B, n = 47). These two groups were not significantly different in sex, weight, age, diagnosis or ambulatory medication. The mean initial dose (± SEM) was 64 ± 2 mg/kg for group A and 93 ± 2 mg/kg for group B. Because adequate sedation was not achieved, 14 patients in group A and 6 in group B required a second dose, giving a mean total dose of 70 ± 2 mg/kg for group A and 96 ± 2 mg/kg for group B. The percentage of successful examinations after the initial dose (A: 64 %, B: 87 %; p 〈 0.05) and the total dose (A: 92 %, B: 100 %; p = 0.14) was higher in group B. Significant differences were found for the time of onset of sedation (A: 28 ± 2 min, B: 21 ± 1 min; p 〈 0.05), but not for the time to spontaneous awakening after the completion of the examination. The rate of adverse reactions was similar (A: 20 %, B: 21 %; p = 1.00). We conclude that high-dose oral chloral hydrate improves the management of children undergoing MRI.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
  • 3
    ISSN: 1432-1084
    Keywords: Key words: Contrast media ; Comparative study ; Computed tomography (CT) ; Iopentol ; Adverse events ; Tolerance
    Source: Springer Online Journal Archives 1860-2000
    Topics: Medicine
    Notes: Abstract. Objectives: Iopentol (Nycomed Imaging AS, Oslo, Norway) and iopromide (Schering AG, Berlin, Germany) are low-osmolar, non-ionic, iodinated contrast media (CM) used in abdominal CT examinations. The intravenous safety profile and radiological efficacy of iopentol and iopromide were studied in 518 patients. Specifically, frequency of adverse events (AEs), subjective change in quality of diagnostic information, and quantitative enhancement characteristics were compared. Materials and methods: A prospective, double-blind, randomized, multicentre, parallel-group study was conducted at 8 hospitals. Patients received 100 ml of either iopentol 300 mg I/ml or iopromide 300 mg I/ml. Results: The incidence of patients with AEs was statistically significantly lower in the iopentol group compared to the iopromide group (2.3 % vs. 8.9 %, p 〈 0.001). Discomfort was frequent in both groups (44.8 % vs. 49.4 %, p = 0.33), sensation of heat and warmth being most common. Overall, diagnostic information was similar in both groups. Both CM gave high percentages of examinations rated as optimal (87.1 % vs. 90.5 %, p = 0.34) and in which diagnostic confidence was increased (87.5 % vs. 91.1 %, p = 0.22). No significant differences between the two CM were found concerning quantitative enhancement characteristics. Conclusions: In this study iopentol was significantly safer than iopromide for contrast enhanced CT examination of the abdomen. Radiological efficacy was similar with both CM.
    Type of Medium: Electronic Resource
    Library Location Call Number Volume/Issue/Year Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...